China’s food and drug administration has cut the time it needs to approve proprietary drugs, while the State Council announced early this month it would slash the corporate tax rate for generic drug makers from the universal 25 per cent to 15 per cent. Photo: Reuters

Chinese investors back drug stocks to weather trade war

Mainland-traded pharma stock prices rise 10pc as a sector in 2018 so far, the best-performing industry on the CSI 300 Index

Topic |   China stock market

TOP PICKS

China’s food and drug administration has cut the time it needs to approve proprietary drugs, while the State Council announced early this month it would slash the corporate tax rate for generic drug makers from the universal 25 per cent to 15 per cent. Photo: Reuters
READ FULL ARTICLE